ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Conditions:   Castration Levels of Testosterone;   Castration-Resistant Prostate Carcinoma;   Metastatic Prostate Carcinoma;   Prostate Carcinoma Metastatic in the Bone;   Stage IVB Prostate Cancer AJCC v8 Interventions:   Drug: Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981;   Biological: Nivolumab Sponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials